Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study

INTRODUCTION: The IGLU-SIT study documented the effectiveness of initiating supplementary prandial insulin treatment (SIT) with insulin glulisine after failure of oral antidiabetic drugs alone in patients with type 2 diabetes (T2DM) in a real-world setting in Germany. METHODS: The IGLU-SIT study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfohl, Martin, Seufert, Jochen, Borck, Anja, Bramlage, Peter, Siegmund, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947113/
https://www.ncbi.nlm.nih.gov/pubmed/33544355
http://dx.doi.org/10.1007/s13300-021-00998-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947113/
https://www.ncbi.nlm.nih.gov/pubmed/33544355
http://dx.doi.org/10.1007/s13300-021-00998-z

Ejemplares similares